Beximco Pharmaceuticals Limited (LON:BXP)
—
Spriggl Score: Strong— sign in to explore; full breakdown with Premium
Last 30 trading days
Spriggl AI Verdict
“Listing restored, dividend returning; deep-value Bangladesh pharma at five times earnings, currency risk persists.”
Sign up free to read the full investment thesis, bull case, bear case and what to watch.
About Beximco Pharmaceuticals Limited
Beximco Pharmaceuticals PLC. manufactures and markets generic pharmaceutical formulations and active pharmaceutical ingredients in Bangladesh. The company provides allergic disorder, analgesics and antipyretic, anti-infective, antiviral, cardiovascular, central nervous system, co…
- Sector:
- Healthcare
- Industry:
- Drug Manufacturers - Specialty & Generic
- Market Cap:
- £259.8M
Recent dividends
- 22 Nov 20242.40p
- 10 Nov 20232.33p
- 17 Nov 20222.44p
Get the full Spriggl analysis — free
A free Spriggl account gets you the screener, a watchlist, AI verdicts and a free full report every day — across Beximco Pharmaceuticals Limited and 1,500+ UK and US stocks. The full score breakdown and AI analysis come with Premium.
Start free